Sign in
4

Changes in Ownership

Celldex Therapeutics, Inc. Filed Acc 0001179110-16-029382

Sr. VP & CFO acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CATLIN AVERY W · Sr. VP & CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-09-02 Exercise or conversion : show line 1 in the form +10,000 $2.80 $28,000 83,586 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-09-02 Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) −10,000 $2.80 2021-08-05 10,000 25,000 D
Loading xslF345X03/edgar.xml…